Goldman Sachs’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $15.5M | Buy |
|
|||||
|
2020
Q4 | $12.3M | Buy |
|
|||||
|
2020
Q3 | $4.37M | Sell |
|
|||||
|
2020
Q2 | $6.94M | Buy |
|
|||||
|
2020
Q1 | $3.3M | Sell |
|
|||||
|
2019
Q4 | $13.9M | Buy |
|
|||||
|
2019
Q3 | $5.37M | Sell |
|
|||||
|
2019
Q2 | $5.11M | Sell |
|
|||||
|
2019
Q1 | $12.2M | Buy |
|
|||||
|
2018
Q4 | $7.29M | Buy |
|
|||||
|
2018
Q3 | $6.4M | Sell |
|
|||||
|
2018
Q2 | $11.2M | Sell |
|
|||||
|
2018
Q1 | $50.6M | Buy |
|
|||||
|
2017
Q4 | $47.1M | Buy |
|
|||||
|
2017
Q3 | $5.77M | Buy |
|
|||||
|
2017
Q2 | $6.95M | Buy |
|
|||||
|
2017
Q1 | $5.86M | Buy |
|
|||||
|
2016
Q4 | $5.75M | Sell |
|
|||||
|
2016
Q3 | $17.4M | Buy |
|
|||||
|
2016
Q2 | $3.96M | Buy |
|
|||||
|
2016
Q1 | $2.58M | Buy |
|
|||||
|
2015
Q4 | $1.65M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $695K | Sell |
|
|||||
|
2015
Q1 | $577K | Buy |
|